Watson to acquire Actavis for EUR 4.3 billion

Watson Pharmaceuticals Inc. (NYSE:WPI) will acquire fellow generics company Actavis Group (Zug, Switzerland) for EUR 4.3 billion ($5.6 billion) in cash. Actavis shareholders could also receive up to 5.5 million Watson shares next year if 2012 performance targets are met. The 5.5 million shares are valued at $383.3 million, based on Watson's Wednesday close of $69.69, up $1.09 on the day. ...